Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma von Flinsenberg, Thijs W H, Tromedjo, Charnelle C, Hu, Nan, Liu, Ye, Guo, Yin, Thia, Kevin Y T, Noori, Tahereh, Song, Xiaomin, Aw Yeang, Han X, Tantalo, Daniela G, Handunnetti, Sasanka, Seymour, John F, Roberts, Andrew W, Ritchie, David, Koldej, Rachel, Neeson, Paul J, Wang, Lai, Trapani, Joseph A, Tam, Constantine S, Voskoboinik, Ilia

Volltext